4 results
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
and patient access, drug pricing and reimbursement. The number of patients in the United States and other major markets and elsewhere may turn out to be lower … criteria for Medicaid programs; expanded the entities eligible for discounts under the 340B drug pricing program; increased the statutory minimum rebates
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
under the 340B drug pricing program; increased the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program; established … Reduction Act of 2022, or IRA, included a number of significant drug pricing reforms, which include the establishment of a drug price negotiation program
DRS
MLYS
Mineralys Therapeutics Inc
4 Nov 22
Draft registration statement
12:00am
access, drug pricing and reimbursement. The number of patients in the United States and other major markets and elsewhere may turn out to be lower than … ; expanded eligibility criteria for Medicaid programs; expanded the entities eligible for discounts under the 340B drug pricing program; increased
- Prev
- 1
- Next